# Question 63

**Type:** Conditional correlation

**Question:** "In breast cancer, what is the correlation coefficient between EGFR expression levels and PIK3CA mutation status considering only patients who also have a homozygous deletion of PTEN?"

**Answer:**

I'll help you explore the correlation between EGFR expression and PIK3CA mutation status in breast cancer patients with PTEN homozygous deletions. Let me start by finding the appropriate breast cancer study.



Calling `resolve_and_route` with args:
```json
{
  "targetPage": "study",
  "studyKeywords": [
    "breast",
    "TCGA"
  ]
}
```



Result from `resolve_and_route`:
```json
{"success":false,"error":"Bad Gateway","details":{"status":502,"response":{"req":{"method":"POST","url":"https://www.cbioportal.org/api/molecular-profiles/fetch?projection=ID","data":{"studyIds":["brca_tcga_pan_can_atlas_2018"]},"headers":{"user-agent":"node-superagent/3.8.3","accept":"application/json","content-type":"application/json"}},"header":{"date":"Thu, 05 Feb 2026 01:53:53 GMT","content-type":"text/html","content-length":"150","connection":"close","strict-transport-security":"max-age=31536000; includeSubDomains"},"status":502,"text":"<html>\r\n<head><title>502 Bad Gateway</title></head>\r\n<body>\r\n<center><h1>502 Bad Gateway</h1></center>\r\n<hr><center>nginx</center>\r\n</body>\r\n</html>\r\n"}}}
```


Let me try again with the routing tool:



Calling `resolve_and_route` with args:
```json
{
  "targetPage": "study",
  "studyKeywords": [
    "breast"
  ]
}
```



Result from `resolve_and_route`:
```json
{"success":true,"message":"Found 37 matching studies (showing top 5 with detailed metadata). Review the user's original query to determine if it clearly matches one study. If yes, use that study's metadata to call navigate_to_studyview. If ambiguous, ask the user to choose.","data":{"recommendedTool":"navigate_to_studyview","needsStudySelection":true,"totalCount":37,"resolvedStudyIds":["msk_met_2021","breast_msk_2025","brca_metabric","breast_msk_2018","brca_tcga","brca_tcga_pub2015","breast_ink4_msk_2021","brca_tcga_pub","brca_tcga_gdc","brca_tcga_pan_can_atlas_2018","brca_msk_2025","brca_mbcproject_2022","brca_aurora_2023","brca_mbcproject_wagle_2017","brca_igr_2015","brca_smc_2018","breast_cptac_gdc","brca_mapk_hp_msk_2021","breast_alpelisib_2020","brca_cptac_2020","brca_bccrc_xenograft_2014","brca_broad","brca_sanger","brca_dldccc_2022","brca_mskcc_2019","brca_fuscc_2020","brca_bccrc","brca_pareja_msk_2020","brca_dfci_2020","brca_iatlas_anders_2022","ilc_msk_2023","bfn_duke_nus_2015","mbc_msk_2021","mixed_msk_tcga_2021","acbc_mskcc_2015","brca_jup_msk_2020","brca_hta9_htan_2022"],"studiesWithMetadata":[{"studyId":"msk_met_2021","name":"MSK MetTropism (MSK, Cell 2021)","sampleCount":25775,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=msk_met_2021","metadata":{"clinicalAttributeIds":["AGE_AT_DEATH","AGE_AT_EVIDENCE_OF_METS","AGE_AT_LAST_CONTACT","AGE_AT_SEQUENCING","AGE_AT_SURGERY","CANCER_TYPE","CANCER_TYPE_DETAILED","DMETS_DX_ADRENAL_GLAND","DMETS_DX_BILIARY_TRACT","DMETS_DX_BLADDER_UT","DMETS_DX_BONE","DMETS_DX_BOWEL","DMETS_DX_BREAST","DMETS_DX_CNS_BRAIN","DMETS_DX_DIST_LN","DMETS_DX_FEMALE_GENITAL","DMETS_DX_HEAD_NECK","DMETS_DX_INTRA_ABDOMINAL","DMETS_DX_KIDNEY","DMETS_DX_LIVER","DMETS_DX_LUNG","DMETS_DX_MALE_GENITAL","DMETS_DX_MEDIASTINUM","DMETS_DX_OVARY","DMETS_DX_PLEURA","DMETS_DX_PNS","DMETS_DX_SKIN","DMETS_DX_UNSPECIFIED","FGA","FRACTION_GENOME_ALTERED","GENE_PANEL","IS_DIST_MET_MAPPED","METASTATIC_SITE","MET_COUNT","MET_SITE_COUNT","MSI_SCORE","MSI_TYPE","MUTATION_COUNT","ONCOTREE_CODE","ORGAN_SYSTEM","OS_MONTHS","OS_STATUS","PRIMARY_SITE","RACE","SAMPLE_COUNT","SAMPLE_COVERAGE","SAMPLE_TYPE","SEX","SUBTYPE","SUBTYPE_ABBREVIATION","TMB_NONSYNONYMOUS","TUMOR_PURITY"],"molecularProfileIds":["msk_met_2021_cna","msk_met_2021_mutations","msk_met_2021_structural_variants"]}},{"studyId":"breast_msk_2025","name":"Breast Cancer (MSK, 2025)","sampleCount":3879,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=breast_msk_2025","metadata":{"clinicalAttributeIds":["CANCER_TYPE","CANCER_TYPE_DETAILED","ETHNICITY","FRACTION_GENOME_ALTERED","GENDER","GENE_PANEL","METASTATIC_SITE","MSI_COMMENT","MSI_SCORE","MSI_TYPE","MUTATION_COUNT","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","PRIMARY_SITE","RACE","SAMPLE_CLASS","SAMPLE_COUNT","SAMPLE_COVERAGE","SAMPLE_TYPE","SOMATIC_STATUS","TUMOR_PURITY"],"molecularProfileIds":["breast_msk_2025_gistic","breast_msk_2025_mutations","breast_msk_2025_structural_variants"]}},{"studyId":"brca_metabric","name":"Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)","sampleCount":2509,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_metabric","metadata":{"clinicalAttributeIds":["AGE_AT_DIAGNOSIS","BREAST_SURGERY","CANCER_TYPE","CANCER_TYPE_DETAILED","CELLULARITY","CHEMOTHERAPY","CLAUDIN_SUBTYPE","COHORT","ER_IHC","ER_STATUS","GRADE","HER2_SNP6","HER2_STATUS","HISTOLOGICAL_SUBTYPE","HORMONE_THERAPY","INFERRED_MENOPAUSAL_STATE","INTCLUST","LATERALITY","LYMPH_NODES_EXAMINED_POSITIVE","MUTATION_COUNT","NPI","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","PR_STATUS","RADIO_THERAPY","RFS_MONTHS","RFS_STATUS","SAMPLE_COUNT","SAMPLE_TYPE","SEX","THREEGENE","TMB_NONSYNONYMOUS","TUMOR_SIZE","TUMOR_STAGE","VITAL_STATUS"],"molecularProfileIds":["brca_metabric_cna","brca_metabric_methylation_promoters_rrbs","brca_metabric_mrna","brca_metabric_mrna_median_all_sample_Zscores","brca_metabric_mutations"]}},{"studyId":"breast_msk_2018","name":"Breast Cancer (MSK, Cancer Cell 2018)","sampleCount":1918,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=breast_msk_2018","metadata":{"clinicalAttributeIds":["CANCER_TYPE","CANCER_TYPE_DETAILED","DFS_EVENT","DFS_MONTHS","ER_PCT_PRIMARY","ER_STATUS","ER_STATUS_PRIMARY","FRACTION_GENOME_ALTERED","HER2_FISH","HER2_FISH_RATIO","HER2_FISH_RATIO_PRIMARY","HER2_FISH_STATUS","HER2_IHC_PRIMARY","HER2_IHC_SCORE","HER2_IHC_STATUS","HER2_IHC_VALUE_PRIMARY","HER2_STATUS_PRIMARY","HR_STATUS","INVASIVE_CARCINOMA_DX_AGE","INVASIVE_CARCINOMA_DX_TIME","LAST_CONTACT_DAYS_TO","LATERALITY","MENOPAUSAL_STATUS_AT_DIAGNOSIS","METASTATIC_DZ_FUP","METASTATIC_RECURRENCE_TIME_MONTHS","MUTATION_COUNT","M_STAGE","NGS_SAMPLE_COLLECTION_TIME","N_STAGE","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OVERALL_HER2_STATUS","OVERALL_HER2_STATUS_PATIENT","OVERALL_HR_STATUS_PATIENT","OVERALL_RECEPTOR_STATUS_PATIENT","OVERALL_TUMOR_GRADE","PRIMARY_NUCLEAR_GRADE","PRIOR_BREAST_PRIMARY","PRIOR_LOCAL_RECURRENCE","PR_PCT_PRIMARY","PR_STATUS","PR_STATUS_PRIMARY","RECEPTOR_STATUS_PRIMARY","SAMPLE_COUNT","SAMPLE_SITE","SAMPLE_TYPE","SEX","SOMATIC_STATUS","STAGE_AT_DIAGNOSIS","TIME_TO_DEATH_MONTHS","TMB_NONSYNONYMOUS","TUMOR_SAMPLE_HISTOLOGY","TUMOR_TISSUE_ORIGIN","T_STAGE","VITAL_STATUS"],"molecularProfileIds":["breast_msk_2018_cna","breast_msk_2018_mutations","breast_msk_2018_structural_variants"]}},{"studyId":"brca_tcga","name":"Breast Invasive Carcinoma (TCGA, Firehose Legacy)","sampleCount":1896,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_tcga","metadata":{"clinicalAttributeIds":["AGE","AJCC_METASTASIS_PATHOLOGIC_PM","AJCC_NODES_PATHOLOGIC_PN","AJCC_PATHOLOGIC_TUMOR_STAGE","AJCC_STAGING_EDITION","AJCC_TUMOR_PATHOLOGIC_PT","BRACHYTHERAPY_TOTAL_DOSE_POINT_A","CANCER_TYPE","CANCER_TYPE_DETAILED","CENT17_COPY_NUMBER","CLINICAL_STAGE","CLIN_M_STAGE","CLIN_N_STAGE","CLIN_T_STAGE","DAYS_TO_COLLECTION","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","DAYS_TO_PATIENT_PROGRESSION_FREE","DAYS_TO_SPECIMEN_COLLECTION","DAYS_TO_TUMOR_PROGRESSION","DFS_MONTHS","DFS_STATUS","DISEASE_CODE","ER_POSITIVITY_SCALE_OTHER","ER_POSITIVITY_SCALE_USED","ER_STATUS_BY_IHC","ER_STATUS_IHC_PERCENT_POSITIVE","ETHNICITY","EXTRANODAL_INVOLVEMENT","FIRST_SURGICAL_PROCEDURE_OTHER","FORM_COMPLETION_DATE","FRACTION_GENOME_ALTERED","HER2_AND_CENT17_CELLS_COUNT","HER2_AND_CENT17_SCALE_OTHER","HER2_CENT17_COUNTED_CELLS_COUNT","HER2_CENT17_RATIO","HER2_COPY_NUMBER","HER2_FISH_METHOD","HER2_FISH_STATUS","HER2_IHC_PERCENT_POSITIVE","HER2_IHC_SCORE","HER2_POSITIVITY_METHOD_TEXT","HER2_POSITIVITY_SCALE_OTHER","HISTOLOGICAL_DIAGNOSIS","HISTOLOGICAL_SUBTYPE","HISTORY_NEOADJUVANT_TRTYN","HISTORY_OTHER_MALIGNANCY","ICD_10","ICD_O_3_HISTOLOGY","ICD_O_3_SITE","IHC_HER2","IHC_SCORE","INFORMED_CONSENT_VERIFIED","INITIAL_PATHOLOGIC_DX_YEAR","IS_FFPE","LONGEST_DIMENSION","LYMPH_NODES_EXAMINED","LYMPH_NODES_EXAMINED_HE_COUNT","LYMPH_NODES_EXAMINED_IHC_COUNT","LYMPH_NODE_EXAMINED_COUNT","MARGIN_STATUS_REEXCISION","MENOPAUSE_STATUS","METASTATIC_SITE_OTHER","METASTATIC_SITE_PATIENT","METASTATIC_TUMOR_INDICATOR","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","METHOD_OF_SAMPLE_PROCUREMENT","MICROMET_DETECTION_BY_IHC","MUTATION_COUNT","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","NTE_CENT17_HER2_OTHER_SCALE","NTE_CENT_17_HER2_RATIO","NTE_CENT_17_SIGNAL_NUMBER","NTE_ER_IHC_INTENSITY_SCORE","NTE_ER_POSITIVITY_DEFINE_METHOD","NTE_ER_POSITIVITY_OTHER_SCALE","NTE_ER_STATUS","NTE_ER_STATUS_IHC_POSITIVE","NTE_HER2_FISH_DEFINE_METHOD","NTE_HER2_FISH_STATUS","NTE_HER2_POSITIVITY_IHC_SCORE","NTE_HER2_POSITIVITY_METHOD","NTE_HER2_POSITIVITY_OTHER_SCALE","NTE_HER2_SIGNAL_NUMBER","NTE_HER2_STATUS","NTE_HER2_STATUS_IHC_POSITIVE","NTE_PR_IHC_INTENSITY_SCORE","NTE_PR_POSITIVITY_DEFINE_METHOD","NTE_PR_POSITIVITY_OTHER_SCALE","NTE_PR_STATUS_BY_IHC","NTE_PR_STATUS_IHC_POSITIVE","OCT_EMBEDDED","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","OTHER_PATIENT_ID","OTHER_SAMPLE_ID","PATHOLOGY_REPORT_FILE_NAME","PATHOLOGY_REPORT_UUID","PATH_MARGIN","PHARMACEUTICAL_TX_ADJUVANT","PRIMARY_SITE_OTHER","PRIMARY_SITE_PATIENT","PROJECT_CODE","PROSPECTIVE_COLLECTION","PR_POSITIVITY_DEFINE_METHOD","PR_POSITIVITY_IHC_INTENSITY_SCORE","PR_POSITIVITY_SCALE_OTHER","PR_POSITIVITY_SCALE_USED","PR_STATUS_BY_IHC","PR_STATUS_IHC_PERCENT_POSITIVE","RACE","RADIATION_TREATMENT_ADJUVANT","RETROSPECTIVE_COLLECTION","SAMPLE_COUNT","SAMPLE_INITIAL_WEIGHT","SAMPLE_TYPE","SAMPLE_TYPE_ID","SEX","SHORTEST_DIMENSION","SITE_OF_TUMOR_TISSUE","SOMATIC_STATUS","SPECIMEN_CURRENT_WEIGHT","SPECIMEN_FREEZING_METHOD","SPECIMEN_SECOND_LONGEST_DIMENSION","STAGE_OTHER","STAGING_SYSTEM","STAGING_SYSTEM_OTHER","SURGERY_FOR_POSITIVE_MARGINS","SURGERY_FOR_POSITIVE_MARGINS_OTHER","SURGICAL_PROCEDURE_FIRST","TIME_BETWEEN_CLAMPING_AND_FREEZING","TIME_BETWEEN_EXCISION_AND_FREEZING","TISSUE_SOURCE_SITE","TMB_NONSYNONYMOUS","TUMOR_STATUS","VIAL_NUMBER"],"molecularProfileIds":["brca_tcga_gistic","brca_tcga_linear_CNA","brca_tcga_methylation_hm450","brca_tcga_mrna","brca_tcga_mrna_median_Zscores","brca_tcga_mrna_median_all_sample_Zscores","brca_tcga_mutations","brca_tcga_phosphoprotein_quantification","brca_tcga_protein_quantification","brca_tcga_protein_quantification_zscores","brca_tcga_rna_seq_v2_mrna","brca_tcga_rna_seq_v2_mrna_median_Zscores","brca_tcga_rna_seq_v2_mrna_median_all_sample_Zscores","brca_tcga_rppa","brca_tcga_rppa_Zscores"]}}],"otherStudies":[{"studyId":"brca_tcga_pub2015","name":"Breast Invasive Carcinoma (TCGA, Cell 2015)","sampleCount":1635,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_tcga_pub2015"},{"studyId":"breast_ink4_msk_2021","name":"Metastatic Breast Cancer (MSK, Cancer Discovery 2022)","sampleCount":1365,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=breast_ink4_msk_2021"},{"studyId":"brca_tcga_pub","name":"Breast Invasive Carcinoma (TCGA, Nature 2012)","sampleCount":1136,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_tcga_pub"},{"studyId":"brca_tcga_gdc","name":"Invasive Breast Carcinoma (TCGA, GDC)","sampleCount":1105,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_tcga_gdc"},{"studyId":"brca_tcga_pan_can_atlas_2018","name":"Breast Invasive Carcinoma (TCGA, PanCancer Atlas)","sampleCount":1084,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_tcga_pan_can_atlas_2018"},{"studyId":"brca_msk_2025","name":"Breast Carcinoma (MSK, NPJ Precis Oncol 2025)","sampleCount":527,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_msk_2025"},{"studyId":"brca_mbcproject_2022","name":"The Metastatic Breast Cancer Project (Provisional, December 2021)","sampleCount":379,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_mbcproject_2022"},{"studyId":"brca_aurora_2023","name":"Metastatic Breast Cancer (AURORA US Network, Nat Cancer 2023)","sampleCount":286,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_aurora_2023"},{"studyId":"brca_mbcproject_wagle_2017","name":"The Metastatic Breast Cancer Project (Archived, 2020)","sampleCount":237,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_mbcproject_wagle_2017"},{"studyId":"brca_igr_2015","name":"Metastatic Breast Cancer (INSERM, PLoS Med 2016)","sampleCount":216,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_igr_2015"},{"studyId":"brca_smc_2018","name":"Breast Cancer (SMC 2018)","sampleCount":187,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_smc_2018"},{"studyId":"breast_cptac_gdc","name":"Breast Cancer (CPTAC GDC, 2025)","sampleCount":154,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=breast_cptac_gdc"},{"studyId":"brca_mapk_hp_msk_2021","name":"MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)","sampleCount":145,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_mapk_hp_msk_2021"},{"studyId":"breast_alpelisib_2020","name":"Breast Cancer (MSK, Nature Cancer 2020)","sampleCount":141,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=breast_alpelisib_2020"},{"studyId":"brca_cptac_2020","name":"Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)","sampleCount":122,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_cptac_2020"},{"studyId":"brca_bccrc_xenograft_2014","name":"Breast Cancer Xenografts (British Columbia, Nature 2015)","sampleCount":117,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_bccrc_xenograft_2014"},{"studyId":"brca_broad","name":"Breast Invasive Carcinoma (Broad, Nature 2012)","sampleCount":103,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_broad"},{"studyId":"brca_sanger","name":"Breast Invasive Carcinoma (Sanger, Nature 2012)","sampleCount":100,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_sanger"},{"studyId":"brca_dldccc_2022","name":"Triple Negative Breast Cancer (DLDCCC, Cancer Discov 2022)","sampleCount":75,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_dldccc_2022"},{"studyId":"brca_mskcc_2019","name":"Breast Cancer (MSK, NPJ Breast Cancer 2019)","sampleCount":70,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_mskcc_2019"},{"studyId":"brca_fuscc_2020","name":"Triple-Negative Breast Cancer (FUSCC, Cell Research 2020)","sampleCount":69,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_fuscc_2020"},{"studyId":"brca_bccrc","name":"Breast Invasive Carcinoma (British Columbia, Nature 2012)","sampleCount":65,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_bccrc"},{"studyId":"brca_pareja_msk_2020","name":"Breast Cancer (MSK, Clinical Cancer Res 2020)","sampleCount":60,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_pareja_msk_2020"},{"studyId":"brca_dfci_2020","name":"Metastatic Breast Cancer (DFCI, Cancer Discov 2020)","sampleCount":59,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_dfci_2020"},{"studyId":"brca_iatlas_anders_2022","name":"Metastatic Triple Negative Breast Cancer (UNC Phase II Trial, J Immunother Cancer 2022) - iAtlas Harmonized","sampleCount":31,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_iatlas_anders_2022"},{"studyId":"ilc_msk_2023","name":"Non-CDH1 Invasive Lobular Carcinoma (MSK, 2023)","sampleCount":25,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=ilc_msk_2023"},{"studyId":"bfn_duke_nus_2015","name":"Breast Fibroepithelial Tumors (Duke-NUS, Nat Genet 2015)","sampleCount":22,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=bfn_duke_nus_2015"},{"studyId":"mbc_msk_2021","name":"Metaplastic Breast Cancer (MSK,NPJ Breast Cancer 2021)","sampleCount":19,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=mbc_msk_2021"},{"studyId":"mixed_msk_tcga_2021","name":"RAD51B Associated Mixed Cancers (MSK, NPJ Breast Cancer 2021)","sampleCount":17,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=mixed_msk_tcga_2021"},{"studyId":"acbc_mskcc_2015","name":"Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)","sampleCount":12,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=acbc_mskcc_2015"},{"studyId":"brca_jup_msk_2020","name":"Juvenile Papillomatosis and Breast Cancer (MSK,J Pathol. 2015)","sampleCount":5,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_jup_msk_2020"},{"studyId":"brca_hta9_htan_2022","name":"Breast Cancer (HTAN, 2022)","sampleCount":5,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=brca_hta9_htan_2022"}]}}
```


I found 37 breast cancer studies in cBioPortal. For your analysis involving EGFR expression, PIK3CA mutations, and PTEN homozygous deletions, I recommend using the **TCGA PanCancer Atlas** study as it has comprehensive molecular data including expression, mutations, and copy number alterations.

However, I need to inform you that **cBioPortal's current interface doesn't directly calculate correlation coefficients between expression levels and mutation status** through the navigation tools I have access to. 

Here's what I can help you do:

## Option 1: Set up the filtered cohort for manual analysis

I can create a StudyView URL that filters for patients with PTEN homozygous deletions in the TCGA Breast Cancer PanCancer Atlas study. From there, you can:
1. Navigate to the Plots tab
2. Set up a plot with EGFR expression on one axis
3. Color points by PIK3CA mutation status
4. Visually assess the correlation (cBioPortal may display correlation statistics in the plot)

Let me set this up for you:



Calling `navigate_to_studyview_page` with args:
```json
{
  "studyIds": [
    "brca_tcga_pan_can_atlas_2018"
  ],
  "filterJson": {
    "geneFilters": [
      {
        "molecularProfileIds": [
          "brca_tcga_pan_can_atlas_2018_gistic"
        ],
        "geneQueries": [
          [
            {
              "hugoGeneSymbol": "PTEN",
              "alterations": [
                "HOMDEL"
              ]
            }
          ]
        ]
      }
    ]
  },
  "tab": "plots"
}
```



Result from `navigate_to_studyview_page`:
```json
{"success":true,"message":"Navigating to https://deploy-preview-5312--cbioportalfrontend.netlify.app/study/plots?id=brca_tcga_pan_can_atlas_2018#filterJson={\"geneFilters\":[{\"geneQueries\":[[{\"alterations\":[\"HOMDEL\"],\"hugoGeneSymbol\":\"PTEN\"}]],\"molecularProfileIds\":[\"brca_tcga_pan_can_atlas_2018_gistic\"]}]}","url":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study/plots?id=brca_tcga_pan_can_atlas_2018#filterJson={\"geneFilters\":[{\"geneQueries\":[[{\"alterations\":[\"HOMDEL\"],\"hugoGeneSymbol\":\"PTEN\"}]],\"molecularProfileIds\":[\"brca_tcga_pan_can_atlas_2018_gistic\"]}]}","data":{"studyIds":["brca_tcga_pan_can_atlas_2018"],"studies":[{"studyId":"brca_tcga_pan_can_atlas_2018","name":"Breast Invasive Carcinoma (TCGA, PanCancer Atlas)","sampleCount":1084}],"tab":"plots","hasFilters":true,"hasPlotsConfig":false}}
```


Perfect! Here's your direct link to explore this analysis:

**ðŸ”— [View PTEN homozygous deletion cohort in Breast Cancer (TCGA PanCancer Atlas) - Plots Tab](https://deploy-preview-5312--cbioportalfrontend.netlify.app/study/plots?id=brca_tcga_pan_can_atlas_2018#filterJson={%22geneFilters%22:[{%22geneQueries%22:[[{%22alterations%22:[%22HOMDEL%22],%22hugoGeneSymbol%22:%22PTEN%22}]],%22molecularProfileIds%22:[%22brca_tcga_pan_can_atlas_2018_gistic%22]}]})**

## How to calculate the correlation:

Once you click the link above:

1. **Configure the X-axis:**
   - Select "Gene" data type
   - Choose EGFR
   - Select the mRNA expression profile (e.g., "mRNA Expression z-Scores")

2. **Configure the Y-axis:**
   - You can either:
     - **Option A:** Set Y-axis to another continuous variable and use the "Color by" feature to color points by PIK3CA mutation status
     - **Option B:** Create a categorical Y-axis based on PIK3CA mutation status

3. **View correlation statistics:**
   - cBioPortal's Plots tab typically displays Pearson or Spearman correlation coefficients when plotting two continuous variables
   - For mutation status (categorical) vs expression (continuous), you may need to assess this visually or export the data

## Option 2: Download data for external analysis

For a precise correlation coefficient calculation, you may want to:
1. Use the link above to identify the PTEN-deleted cohort
2. Click the "Download" tab to export clinical and molecular data
3. Perform the correlation analysis in R, Python, or your preferred statistical software

This approach gives you full control over the statistical method (point-biserial correlation for continuous vs binary data).

---

**Note:** The TCGA PanCancer Atlas Breast Cancer study contains 1,084 samples with comprehensive mutation, CNA, and expression data, making it ideal for this type of multi-omic correlation analysis.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 26.938779094954953
- **agent_type**: mcp-navigator-agent

### Usage
- **input_tokens**: 100362
- **output_tokens**: 1208
- **total_tokens**: 101570
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 01:54:15*